Phuturdex › Diseases › Necrosis
Drugs in development · updated 30 October 2026
Necrosis: drugs in development
As of 30 October 2026 there are 3 active clinical trials (recruiting or ongoing, phases I–III) on 9 drugs for necrosis. 0 are experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| GentamicinGentamicine, Garamycin® | III | 1 | NCT06387147 |
| MetronidazoleLikmez Oral Suspension, Nuvessa® | III | 1 | NCT06387147 |
| LevetiracetamSpritam®, Elepsia Xr® | II | 1 | NCT07130786 |
| CisplatinCis Platinum, Cisplatine | I | 1 | NCT04847063 |
| DoxorubicinAdriamycin, Doxorubincin | I | 1 | NCT04847063 |
| Fluorouracil5-Fluorouracil, Adrucil | I | 1 | NCT04847063 |
| Mitomycin CMitomycin, Jelmyto | I | 1 | NCT04847063 |
| OxaliplatinOxaliplatine, Oxaliplain | I | 1 | NCT04847063 |
| Sodium Thiosulfatetiosulfate, Pedmark® | I | 1 | NCT04847063 |
Sorted by most advanced phase and number of active trials.
All 9 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Myocardial infarction 26 drugs
- Myocardial infarction with ST segment elevation 22 drugs
- Ischemic stroke 94 drugs
- Cardiogenic shock 13 drugs
- Stroke 70 drugs
- Cardiovascular disease 71 drugs
- Cerebral infarction 7 drugs
- Heart failure 104 drugs
- Inflammation 85 drugs
- Acute coronary syndrome 17 drugs
- Coronary artery disease 34 drugs
- Atherosclerosis 34 drugs
Broader categories
- Neoplasm 671 drugs
- Female urogenital disease 11 drugs
- Female urogenital diseases and pregnancy complications 3 drugs
- Urogenital Diseases 16 drugs
- Digestive System Diseases 36 drugs
- Brain Diseases 23 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D009336 “Necrosis”.